A new assay for Lyme disease has been developed. While the assay has been tested extensively in Maine, a group of inventors are planning to test it in Southern California. In comparison to the assay's performance in Maine, testing the assay in Southern California would affect the performance of the assay in which of the following ways?

Greater likelihood that an individual with a negative test will truly not have Lyme disease

Greater likelihood that an individual with a positive test will truly have Lyme disease

Decreased positive likelihood ratio of the Lyme disease assay

Decrease negative likelihood ratio of the Lyme disease assay

Lower likelihood that a patient without Lyme disease truly has a negative test

A 20-year-old man presents to the emergency department with complaints of severe malaise, fevers, and sore throat for the past 7 days. He also has had episodes of nausea and vomiting during this period. He does not smoke or drink alcohol. There is no family history of liver disease. His blood pressure is 130/80 mm Hg, temperature is 38.3℃ (100.9℉), pulse is 102/min, and respiratory rate is 20/min. On physical examination, he appears ill with bilateral cervical lymphadenopathy. His tonsils are erythematous and enlarged. There is no jaundice and he is mildly dehydrated. Abdominal examination demonstrates splenomegaly. The laboratory findings are shown below: Hemoglobin 15 g/dL Platelet count 95,000/mm³ Leukocytes 13,500/mm³ Neutrophils 50% Atypical lymphocytes 34% AST 232 U/L ALT 312 U/L ALP 120 U/L GGT 35 U/L Total bilirubin 1.2 mg/dL Direct bilirubin 0.2 mg/dL PT 12 seconds The serologic test for hepatitis A, B, and C, CMV, and leptospirosis are negative. Serology for both serum IgM and IgG antibodies for EBV capsid antigen are positive, but the heterophile antibody test is negative. What is the most likely reason for the negative heterophile test?

Concurrent viral hepatitis A infection

A 6-month-old male presents for a routine visit to his pediatrician. Two months ago, the patient was seen for tachypnea and wheezing, and diagnosed with severe respiratory syncytial virus (RSV) bronchiolitis. After admission to the hospital and supportive care, the patient recovered and currently is not experiencing any trouble breathing. Regarding the possibility of future reactive airway disease, which of the following statements is most accurate?

“Your child has a greater than 20% chance of developing asthma”

“There is no clear relationship between RSV and the development of asthma.”

“Your child’s risk of asthma is less than the general population.”

“Your child has a less than 5% chance of developing asthma”

“Your child’s risk of asthma is the same as the general population.”

A pharmaceutical company develops a sequential testing protocol for a rare genetic disorder (prevalence 0.01%). Initial screening test has sensitivity 95% and specificity 90%. Positive results undergo confirmatory testing with sensitivity 99% and specificity 99.5%. The company claims this approach achieves PPV >80% for the final positive result. Evaluate this claim and the rationale for sequential testing in this context.

The claim is true; sequential testing increases PPV by enriching the population tested in the second step

The claim is false; sensitivity decreases with sequential testing, reducing PPV

Sequential testing is unnecessary; the first test alone achieves adequate PPV

The claim is false; sequential testing cannot achieve PPV >80% with such low prevalence

The claim is true; the high specificity of the confirmatory test ensures high PPV regardless of prevalence

A hospital system is implementing a sepsis screening algorithm using clinical criteria with sensitivity of 92% and specificity of 75%. False positives result in unnecessary antibiotics, cultures, and ICU evaluations costing $3,000 per case. Missing true sepsis cases (false negatives) results in average increased mortality and morbidity costs of $50,000 per case. Hospital sepsis prevalence is 8%. Evaluate the optimal threshold adjustment strategy.

Decrease threshold to improve sensitivity despite more false positives

Maintain current threshold as it balances sensitivity and specificity equally

Implement risk stratification with different thresholds for different populations

Abandon screening due to unacceptable false positive rate

Increase threshold to improve specificity and reduce costs from false positives

A 58-year-old man with chronic cough undergoes evaluation for tuberculosis. A tuberculin skin test (TST) is positive (15mm induration). TST has sensitivity of 80% and specificity of 95% in immunocompetent adults. However, he received BCG vaccination as a child in Asia. Local TB prevalence is 0.5%, but his occupational exposure increases his pre-test probability to 10%. Evaluate the most appropriate interpretation and management approach.

Calculate post-test probability and obtain interferon-gamma release assay (IGRA)

Repeat TST in 2 weeks to confirm

Treat empirically regardless of test characteristics

Positive test confirms TB; start treatment immediately

False positive due to BCG; no further testing needed

Negative predictive value for USMLE Step 2 CK: High-Yield Behavioral Science Lessons

Negative Predictive Value - The 'All Clear' Signal

Negative Predictive Value (NPV) is the probability that a subject with a negative test result is a true negative. It answers the question: "If my test is negative, how likely is it that I don't have the disease?"

⭐ NPV is the probability that a person with a negative test result is truly free of the disease.

Formula: $NPV = \frac{TN}{TN + FN}$
- TN: True Negative
- FN: False Negative

2x2 table for sensitivity, specificity, PPV, and NPV

Prevalence Impact:
- NPV is inversely related to prevalence.
- As prevalence ↓, NPV ↑.
- 📌 NPV's value shines when prevalence is low. A negative result in a low-prevalence setting is very reassuring.

NPV & Prevalence - By Population Possessed

Negative Predictive Value (NPV) is critically dependent on disease prevalence (or pre-test probability) in the tested population. It is NOT an intrinsic property of the test itself.
The relationship is inverse:
- As prevalence ↓, NPV ↑.
- As prevalence ↑, NPV ↓.
This contrasts with Sensitivity and Specificity, which are fixed characteristics of a diagnostic test and do not change with prevalence.

NPV and PPV vs. Prevalence and Cut-off

⭐ In a population with very low disease prevalence, a negative test result is very reassuring. Even a test with mediocre specificity can achieve a very high NPV, because true negatives will vastly outnumber false negatives.

Clinical Utility - Master of Ruling Out

High Negative Predictive Value (NPV) is the cornerstone for ruling out disease. When a test has a high NPV, a negative result provides strong evidence that the patient does not have the condition, making it a master of exclusion.

Primary Goal: To confidently exclude a diagnosis, minimizing false negatives.
Best Application: Screening tests in low-prevalence populations. As disease prevalence ↓, the NPV of a test ↑.
Tool of Choice: Use a high-sensitivity test.
- Example: Using a D-dimer test (high sensitivity) for a patient with low pre-test probability of pulmonary embolism (PE). A negative result effectively rules out PE.

⭐ SNOUT: A highly SeNsitive test, when Negative, rules OUT the disease. This is the strategy to achieve a high NPV.

High‑Yield Points - ⚡ Biggest Takeaways

Negative Predictive Value (NPV) is the probability of being truly disease-free given a negative test result.

It is inversely proportional to prevalence; as disease prevalence ↓, NPV ↑.

A negative result is most reassuring and useful when the pre-test probability (prevalence) is low.

Tests with high sensitivity have a high NPV, making them excellent for ruling out disease (SnNout).

Answers the patient's question: "If my test is negative, what is the chance I don't have the disease?"

Continue reading on Oncourse

CONTINUE READING — FREE

or get the app

App Store|Google Play